240 related articles for article (PubMed ID: 28358222)
1. Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study.
Liu T; Jain A; Fung M; Vinnard C; Ivaturi V
Curr Eye Res; 2017 Jul; 42(7):1035-1038. PubMed ID: 28358222
[TBL] [Abstract][Full Text] [Related]
2. Comparing Treatment of Acute Retinal Necrosis With Either Oral Valacyclovir or Intravenous Acyclovir.
Baltinas J; Lightman S; Tomkins-Netzer O
Am J Ophthalmol; 2018 Apr; 188():173-180. PubMed ID: 29447915
[TBL] [Abstract][Full Text] [Related]
3. Primary treatment of acute retinal necrosis with oral antiviral therapy.
Emerson GG; Smith JR; Wilson DJ; Rosenbaum JT; Flaxel CJ
Ophthalmology; 2006 Dec; 113(12):2259-61. PubMed ID: 16996614
[TBL] [Abstract][Full Text] [Related]
4. Vitreous penetration of orally administered valacyclovir.
Huynh TH; Johnson MW; Comer GM; Fish DN
Am J Ophthalmol; 2008 Apr; 145(4):682-6. PubMed ID: 18226802
[TBL] [Abstract][Full Text] [Related]
5. Acute Retinal Necrosis Caused by the Zoster Vaccine Virus.
Heath G; Depledge DP; Brown JR; Hale AD; Tutil H; Williams R; Breuer J
Clin Infect Dis; 2017 Nov; 65(12):2122-2125. PubMed ID: 29020238
[TBL] [Abstract][Full Text] [Related]
6. Extrapolation of Valacyclovir Posology to Children Based on Pharmacokinetic Modeling.
Kechagia IA; Kalantzi L; Dokoumetzidis A
Pediatr Infect Dis J; 2015 Dec; 34(12):1342-8. PubMed ID: 26379165
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
Beutner KR
Antiviral Res; 1995 Dec; 28(4):281-90. PubMed ID: 8669888
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.
Zeng L; Nath CE; Blair EY; Shaw PJ; Stephen K; Earl JW; Coakley JC; McLachlan AJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2918-27. PubMed ID: 19414579
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults.
Cunha BA; Baron J
J Chemother; 2017 Apr; 29(2):122-125. PubMed ID: 26239190
[No Abstract] [Full Text] [Related]
10. Valacyclovir in the treatment of acute retinal necrosis.
Taylor SR; Hamilton R; Hooper CY; Joshi L; Morarji J; Gupta N; Lightman SL
BMC Ophthalmol; 2012 Sep; 12():48. PubMed ID: 22947428
[TBL] [Abstract][Full Text] [Related]
11. Systemic side effects of antiviral therapy in a patient with acute retinal necrosis.
Guney E; Akcay BI; Erdogan G; Unlu C; Bozkurt K; Onur U
Ocul Immunol Inflamm; 2014 Jun; 22(3):233-5. PubMed ID: 24063786
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.
Schoenberger SD; Kim SJ; Thorne JE; Mruthyunjaya P; Yeh S; Bakri SJ; Ehlers JP
Ophthalmology; 2017 Mar; 124(3):382-392. PubMed ID: 28094044
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute retinal necrosis syndrome with oral antiviral medications.
Aizman A; Johnson MW; Elner SG
Ophthalmology; 2007 Feb; 114(2):307-12. PubMed ID: 17123607
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus retinitis: successful evolution with a combination of antiviral therapies.
Oueghlani E; Baglivo E; Durakovic O; Safran AB
Klin Monbl Augenheilkd; 2005 Mar; 222(3):264-6. PubMed ID: 15785997
[TBL] [Abstract][Full Text] [Related]
15. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
Eksborg S; Pal N; Kalin M; Palm C; Söderhäll S
Med Pediatr Oncol; 2002 Apr; 38(4):240-6. PubMed ID: 11920787
[TBL] [Abstract][Full Text] [Related]
17. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.
Wong R; Pavesio CE; Laidlaw DA; Williamson TH; Graham EM; Stanford MR
Ophthalmology; 2010 Mar; 117(3):556-60. PubMed ID: 20031221
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
Garré B; Shebany K; Gryspeerdt A; Baert K; van der Meulen K; Nauwynck H; Deprez P; De Backer P; Croubels S
Antimicrob Agents Chemother; 2007 Dec; 51(12):4308-14. PubMed ID: 17846132
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestation of self-limiting acute retinal necrosis.
Brydak-Godowska J; Borkowski P; Szczepanik S; Moneta-Wielgoś J; Kęcik D
Med Sci Monit; 2014 Oct; 20():2088-96. PubMed ID: 25356955
[TBL] [Abstract][Full Text] [Related]
20. Progression of varicella-zoster virus necrotizing retinopathy in an HIV-negative patient with transient immune deviation.
Lim WK; Chee SP; Nussenblatt RB
Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):607-9. PubMed ID: 15657772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
